Home/Investors/National Institute of Allergy and Infectious Diseases (NIAID)

National Institute of Allergy and Infectious Diseases (NIAID)

Biotech Investor · 4 portfolio companies

Portfolio
4
Focus Areas
8
Top Stage
Pre-clinical

Portfolio Companies

CompanyValuation
Kovina Therapeutics
Eldec Pharmaceuticals
Claremont BioSolutions
Vitalex Biosciences